Patient Preference With Visicol Tablet Preparation for Colonoscopy

Completed

• Conditions: Preparation for Colonoscopy

• Registration Number: NCT00318305
• Lead Sponsor: Mayo Clinic

Brief Summary

The purpose of this study is to determine patient preference and acceptance of tablet sodium phosphate bowel preparation in patients who had polyethylene glycol (PEG) solution for their prior colonoscopy. This study will provide answers related to the patient preferences and their acceptance of this new method of bowel preparation.

Detailed Description

Not available

Study Timeline

• Study Start: 2005-03
• Primary Completion: 2006-04
• Study Completion: 2006-04
• Study First Submitted: 2006-04-24
• Study First Submitted QC: 2006-04-24
• Study First Posted: 2006-04-26
• Status Verified: 2009-12
• Last Update Submitted: 2009-12-01
• Last Update Posted: 2009-12-02

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 53

Inclusion Criteria

• Prior colonoscopy with PEG solution in the past one year
• Must be able to swallow tablets

Exclusion Criteria

• Patients below 18 years and above 100 years.
• Congestive heart failure
• Chronic renal failure
• Pre-existing electrolyte disorder
• Pre-existing mega-colon or a motility disorder.
• Patients with pre-existing seizure disorder.
• Patients scheduled for colonoscopy after 1:00 p.m. will be excluded from the study.
• Pregnant or lactating women

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Trial Locations

Locations (1)

Mayo Clinic; 🇺🇸 Scottsdale, Arizona, United States